Odihale G 50 Inhaler

Introduction

Odihale G is a prescription medication that combines three active ingredients: Vilanterol, Fluticasone Furoate, and Glycopyrronium. It is available in the form of an inhaler and is primarily used for the management of chronic obstructive pulmonary disease (COPD) in adults.

Uses

Odihale G is prescribed to help control and prevent symptoms of COPD, including shortness of breath, wheezing, coughing, and chest tightness. It is not intended for the relief of acute bronchospasm or asthma symptoms.

Dosage and Administration

The dosage and administration of Odihale G should be determined by a healthcare professional based on the individual patient’s condition and response to treatment. Follow the prescribed dose and frequency exactly as instructed. Typically, the recommended dose is one inhalation twice daily, approximately 12 hours apart. The inhaler should be shaken well before each use and primed if it has not been used for more than 7 days.

Mechanism of Action

Odihale G contains three active ingredients that work together to manage symptoms of COPD. Vilanterol is a long-acting beta2-adrenergic agonist that helps relax the muscles in the airways, making it easier to breathe. Fluticasone Furoate is an inhaled corticosteroid that reduces inflammation in the airways, reducing the frequency and severity of COPD symptoms. Glycopyrronium is an anticholinergic agent that helps relax the muscles in the airways, further improving breathing capacity.

Side Effects

Common side effects may include headache, throat irritation, cough, and fungal infections in the mouth and throat. If these side effects persist or worsen, consult a healthcare professional. Serious side effects are rare but may include increased heart rate, chest pain, high blood pressure, and allergic reactions. If any of these serious side effects occur, seek immediate medical attention.

Drug Interactions

Odihale G may interact with certain medications, potentially affecting its effectiveness or increasing the risk of side effects. Inform your healthcare provider about all medications, including over-the-counter drugs and herbal supplements, that you are currently taking. Common drug interactions may occur with other beta2-adrenergic agonists, anticholinergic agents, and certain antifungal medications. Serious drug interactions may occur with monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants. Your healthcare provider can provide further guidance on potential drug interactions.

Precautions

Before using Odihale G, inform your healthcare provider about any medical conditions you have, especially if you have a history of heart problems, high blood pressure, diabetes, seizures, or thyroid problems. Disclose any allergies or sensitivities to medications. Odihale G should not be used in patients with a known hypersensitivity to any of its components. It is not recommended for use in children or adolescents.

Storage

Patient Tips

• Follow the prescribed dosage and administration instructions carefully.
• Do not exceed the recommended dose without consulting your healthcare provider.
• If you have any questions or concerns about using Odihale G, consult your healthcare provider or pharmacist.
• Keep track of how often you need to refill your inhaler to ensure you always have an adequate supply.
• If you experience any unusual or persistent side effects, contact your healthcare provider promptly.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Fluticasone skin creams: a medicine to treat itching, swollen and irritated skin. (NHS UK) [Accessed 6 Jun. 2024] (online) Available at:
• Avamys 27.5 micrograms/spray, nasal spray suspension (Health Professionals SmPC) Available at:
• Fluticasone inhalation (Drugs.com) [Accessed 27 Jun. 2024] (online) Available at:
• fluticasone furoate 100 mcg/actuation blister powder for inhalation (RX) [Accessed 7 Jun. 2024] (online) Available at:
• Allergy Medications: Know Your Options (Mayo Foundation for Medical Education and Research) [Accessed 14 Jun. 2024] (online) Available at:
• Ismaila AS, Haeussler K, Czira A, Youn JH, Malmenäs M, Risebrough NA, Agarwal J, Nassim M, Sharma R, Compton C, Vogelmeier CF, Han MK, Halpin DMG. Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Adv Ther. 2022 Sep;39(9):3957-3978. doi: 10.1007/s12325-022-02231-0. Epub 2022 Jul 17. [Accessed 8 Jun. 2024] Available at: